Aadi Bioscience (FRA:3350) Change In Inventory : €-0.75 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Aadi Bioscience Change In Inventory?

Aadi Bioscience's change in inventory for the quarter that ended in Mar. 2024 was €0.45 Mil. It means Aadi Bioscience's inventory declined by €0.45 Mil from Dec. 2023 to Mar. 2024 .

Aadi Bioscience's change in inventory for the fiscal year that ended in Dec. 2023 was €-2.99 Mil. It means Aadi Bioscience's inventory increased by €2.99 Mil from Dec. 2022 to Dec. 2023 .

Aadi Bioscience's Total Inventories for the quarter that ended in Mar. 2024 was €5.46 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Aadi Bioscience's Days Inventory for the quarter that ended in Mar. 2024 was 863.45.

Inventory Turnover measures how fast the company turns over its inventory within a year. Aadi Bioscience's Inventory Turnover for the quarter that ended in Mar. 2024 was 0.11.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Aadi Bioscience's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 1.15.

Aadi Bioscience Change In Inventory Historical Data

The historical data trend for Aadi Bioscience's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aadi Bioscience Change In Inventory Chart

Aadi Bioscience Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Change In Inventory

-1.76

-2.99

Aadi Bioscience Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Inventory	Get a 7-Day Free Trial										-1.81	0.54	0.30	-2.04	0.45

Aadi Bioscience Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.75 Mil.

Aadi Bioscience (FRA:3350) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Aadi Bioscience's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	5.6775	/	0.6	*	365 / 4
	=	863.45

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Aadi Bioscience's Inventory Turnover for the quarter that ended in Mar. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.6	/	5.6775
	=	0.11

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Aadi Bioscience's Inventory to Revenue for the quarter that ended in Mar. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	5.6775	/	4.925
	=	1.15

Aadi Bioscience Change In Inventory Related Terms

Thank you for viewing the detailed overview of Aadi Bioscience's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Aadi Bioscience (FRA:3350) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aadi Bioscience Inc (FRA:3350) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

AADI:USA 3350:Germany

Address

17383 Sunset Boulevard, Suite A250, Pacific Palisades, CA, USA, 90272

Website

https://www.aadibio.com

Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.

Aadi Bioscience (FRA:3350) Headlines

No Headlines